STUART THERAPEUTICS
Stuart Therapeutics is a biotechnology company that offers PolyCol, a therapeutic platform for ophthalmic indications. PolyCol’s unique method of action results in accelerated healing and recovery in various ophthalmic disease states and offers a new way to address indications such as dry eye disease, dry age related macular degeneration, and glaucoma. PolyCol is based on patented research from a major U.S. university, combined with additional intellectual property acquired by Stuart Therapeutics. The company has developed applications for PolyCol in treating certain ophthalmic, gastrointestinal, inflammatory, and oncology conditions.
STUART THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2017-01-01
Address:
Stuart, Florida, United States
Country:
United States
Website Url:
http://www.stuarttherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
(772) 678-7307
Email Addresses:
[email protected]
Total Funding:
11 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Casma Therapeutics
Casma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Current Employees Featured
Founder
Investors List
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation investment in Series A - Stuart Therapeutics
InFocus Capital Partners
InFocus Capital Partners investment in Series A - Stuart Therapeutics
BioBrit
BioBrit investment in Series A - Stuart Therapeutics
MiMo Capital
MiMo Capital investment in Series A - Stuart Therapeutics
Official Site Inspections
http://www.stuarttherapeutics.com Semrush global rank: 3.82 M Semrush visits lastest month: 3.49 K
- Host name: 172.67.170.3
- IP address: 172.67.170.3
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago